New — Free Peptide Starter Guide (2026): 13 chapters, 34 cited studies

Get it free

Testagen

Also known as: Lys-Glu-Asp-Gly, Khavinson testes peptide, Testicular bioregulator

Testagen is a tetrapeptide bioregulator (Lys-Glu-Asp-Gly) developed by Professor Vladimir Khavinson, tissue-specific for the testes. It supports Leydig cell function, normalization of testosterone biosynthesis, and spermatogenic activity. Testagen is used in men's health protocols for age-related testosterone decline, male fertility support, and testicular anti-aging.

Half-Life

Short (minutes); sustained gene-regulatory effects

Route

SubQ, Oral

Category

Anti-Aging & Longevity

Studies

8 references

Key Benefits

  • Supports endogenous testosterone synthesis via Leydig cell normalization
  • Promotes spermatogenesis and sperm quality
  • Anti-aging effects on testicular tissue
  • May attenuate age-related testosterone decline
  • Mechanistically distinct from TRT — does not suppress HPG axis
  • Useful adjunct to Gonadorelin and Kisspeptin-10 in male hormonal protocols
  • Supports male fertility without exogenous hormone replacement

Mechanism of Action

Testagen's tetrapeptide Lys-Glu-Asp-Gly modulates gene expression in Leydig cells and Sertoli cells of the testes. In Leydig cells, it normalizes steroidogenesis-related gene expression, supporting endogenous testosterone synthesis. In Sertoli cells, it promotes spermatogenesis. By acting at the chromatin level, it restores more youthful patterns of testicular protein synthesis without directly introducing exogenous androgens, making it mechanistically distinct from TRT.

Dosing Protocols

Standard Khavinson Protocol

Dose
10 mg per day
Frequency
Daily for 10–30 days
Timing
Subcutaneous injection or oral (enteric-coated)
Cycle
10–30 day course, repeated 2–4x per year

Often combined with Prostamax and Epithalon in men's anti-aging longevity protocols. Research use only.

Calculate your draw volume

Enter your vial size and BAC water to get exact injection volumes

Calculate dose →

Side Effects

  • Generally well tolerated
  • Mild injection site reactions
  • No significant endocrine disruption reported at standard doses

Contraindications

Not FDA approved. Not a substitute for TRT in diagnosed hypogonadism. Medical oversight required if used alongside hormonal therapies.

Storage

Store at 2–8°C. Protect from moisture and light.

  1. 1.
    The Inhibitory Effect and Adsorption Properties of Testagen Peptide on Copper Surfaces in Saline Environments: An Experimental and Computational Study

    Dobriţescu A, Samide A, Cioateră N, Mic OC, Ionescu C, Dăbuleanu I et al. · Molecules (Basel, Switzerland) · 2025PubMed Verified

  2. 2.
  3. 3.
    Effect of peptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly on the morphology of the thymus in hypophysectomized young and old birds

    Pateyk AV, Baranchugova LM, Rusaeva NS, Obydenko VI, Kuznik BI · Bulletin of experimental biology and medicine · 2013PubMed Verified

  4. 4.
    Interaction of short peptides with FITC-labeled wheat histones and their complexes with deoxyribooligonucleotides

    Fedoreyeva LI, Smirnova TA, Kolomijtseva GY, Khavinson VKh, Vanyushin BF · Biochemistry. Biokhimiia · 2013PubMed Verified

  5. 5.
    Effects of peptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly on hormonal activity and structure of the thyroid gland in hypophysectomized young chickens and old hens

    Kuznik BI, Pateyuk AV, Rusaeva NS, Baranchugova LM, Obydenko VI · Bulletin of experimental biology and medicine · 2011PubMed Verified

  6. 6.
    Effect of tetrapeptides Lys-Glu-Asp-Gly and Ala-Glu-Asp-Gly on the structure and function of the thyroid gland in neonatally hypophysectomized chickens

    Kuznik BI, Pateyuk AV, Rusaeva NS · Bulletin of experimental biology and medicine · 2008PubMed Verified

  7. 7.
    Molecular organization of the protein A gene and its expression in recombinant host organisms

    Colbert D, Anilionis A, Gelep P, Farley J, Breyer R · Journal of biological response modifiers · 1984PubMed Verified

  8. 8.
    Purification and primary structure of two neuroactive peptides that cause bag cell afterdischarge and egg-laying in Aplysia

    Heller E, Kaczmarek LK, Hunkapiller MW, Hood LE, Strumwasser F · Proceedings of the National Academy of Sciences of the United States of America · 1980PubMed Verified

Medical disclaimer: This information is for educational purposes only and does not constitute medical advice. Many compounds listed are research chemicals not approved for human use. Always consult a qualified healthcare professional before starting any protocol.

Was this page helpful?

Launching soon

Build and track your protocol in Staqk

Log doses, track timing, monitor biomarkers, and manage every compound in your stack — all in one place.

Free early access updates. No spam.